Yahoo Finance Top Research Reports for Abbott, T-Mobile & Booking
Thursday, February 1, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) and Booking Holdings Inc. (BKNG). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Abbott’s shares have outperformed the Zacks Medical - Products industry over the past year (+2.8% vs. +2.2%). The company’s pipeline is generating several new growth prospects, which will help sustain the positive momentum and contribute to the strong growth projection in 2024.
Alinity, the company’s next-generation suite of systems, is a key driver in the core lab diagnostics business. EPD's impressive stretch of strong performance stems from the company’s unique business model. Freestyle Libre CGM device is also on a great trajectory, continually outpacing market growth.
Within Nutrition, after a period of hiccups, Abbott has finally reestablished itself as the market leader in the infant formula business, underscoring strong customer confidence in the company's products. However, the slump in COVID-19 testing-related sales is hurting Abbott’s overall growth. Tough macro conditions also pose a concern for its operations.
(You can read the full research report on Abbott here >>>)
Shares of T-Mobile have outperformed the Zacks Wireless National industry over the past year (+10.2% vs. +2.8%). The company recorded 5.7 million postpaid net customer additions and 2.1 million high-speed Internet net customer additions in fiscal 2023. Both metrics are reportedly the best in the industry.
Its 5G coverage exceeds 330 million people, a greater footprint than AT&T and Verizon combined. A higher adjusted free cash flow highlights efficiency in operations and implies that the company is well-positioned to invest in growth initiatives, pay debts and dividends.
However, lower sales of prepaid and Assurance Wireless devices affected revenue from Equipment sales. Weak demand for prepaid services and declining prepaid ARPU is a headwind. High debt burden and macroeconomic challenges remain concerns.
(You can read the full research report on T-Mobile here >>>)
Shares of Booking have outperformed the Zacks Internet - Commerce industry over the past year (+42.9% vs. +18.3%). The company is benefiting from substantial improvement in its booking trends. Growing demand for travel and solid momentum in booked room nights are driving growth in the gross bookings. Further, strong global leisure travel demand is a plus.
Furthermore, solid momentum across merchant, advertising and other businesses is a major positive. Additionally, strong growth in rental car and airline ticket units is acting as a tailwind. For 2023, the company expects more than 20% year-over-year growth in gross bookings.
Additionally, strengthening alternative accommodation business and flight capabilities are a positive. However, weakness in agency bookings is a headwind. Further, intensifying competition remains a major concern.
(You can read the full research report on Booking here >>>)
Other noteworthy reports we are featuring today include Chubb Limited (CB), HCA Healthcare, Inc. (HCA) and KLA Corporation (KLAC).
Director of Research
Sheraz Mian
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Strength in EPD Arm Aids Abbott (ABT), CGM Scope Solid
T-Mobile (TMUS) Rides on Solid Demand for Postpaid Services
Solid Gross Bookings Momentum Aids Booking Holdings (BKNG)
Featured Reports
Better Rate, Increased Exposure Aid Chubb (CB), Cat Loss Ail
Per the Zacks analyst, Chubb is set to grow on better rate environment, increasing exposures and market share, solid capital position and cash generation capabilities. Yet, exposure to cat loss ails.
Rising Admissions Aid HCA Healthcare (HCA), High Costs Hurt
Per the Zacks analyst, HCA Healthcare's strategic acquisitions and rising admissions should continue to aid the top line in the future. However, escalating expenses remain a concern for the company.
KLA (KLAC) Rides on Strong Wafer Inspection Business
Per the Zacks analyst, KLA is benefiting from strong performance of 8900 Series platform for high throughput macro inspection.
Marathon (MPC) to Gain from Sale of Speedway Retail Unit
The Zacks analyst likes Marathon's sale of Speedway business and the resulting cash infusion but is worried over the execution risk associated with its foray into renewable diesel activities.
Sysco's (SYY) Focus on Recipe For Growth Program Bodes Well
Per the Zacks analyst, Sysco is on track with Recipe for Growth program to drive growth. The Recipe for Growth plan will fuel the company's top-and bottom-line growth in fiscal 2024.
Solid Budget Aids Teledyne (TDY), Strengthening Dollar Hits
Per the Zacks Analyst, increased U.S. defense budget boost growth prospects for Teledyne. Yet, strengthening U.S. dollar is impacting airlines' performance that may hurt the stock.
Solid Acquisition Efforts Aid EMCOR (EME), High Costs Ail
Per the Zacks analyst, EMCOR benefits from solid end-market demand and strategic acquisitions. However, inflationary pressures are potential risks.
New Upgrades
Zillow Group (ZG) Rides on Portfolio Strength, Solid Demand
Per the Zacks analyst, Zillow Group is likely to benefit from strong growth in loan origination and healthy improvement in rental revenues driven by growth in both multi and single-family listings.
Solid Demand, Pricing Actions Aid Carpenter Technology (CRS)
Per the Zacks analyst, Carpenter Technology is gaining from strong demand across its end-use markets. Cost-reduction initiatives and efforts to preserve liquidity are also driving growth.
Kodiak (KOD) Boosted by Tarcocimab Study Reboot
Per the Zacks Analyst, rebooting the tarcocimab program across three eye disease indications brings back a late-stage study candidate to Kodiak's clinical-stage pipeline.
New Downgrades
Cash Flow Challenges, High Debt Exposure Ail SM Energy (SM)
Per the Zacks analyst, SM Energy has been facing challenges in converting operating profits to free cash flow efficiently within a specified timeframe. High debt exposure is an added concern.
Air Lease (AL) Grapples With Rising Expenses & High Debt
The Zacks Analyst is worried about the fact that rising operating expenses are likely to keep AL's bottom line under pressure. A debt-laden balance sheet is another concern.
Higher Costs, Customer De-stocking Ail Ingevity (NGVT)
Per the Zacks analyst, Ingevity is grappling with higher raw material, freight and logistics costs. Customer de-stocking is also hurting its industrial specialties business.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Abbott Laboratories (ABT) : Free Stock Analysis Report
Chubb Limited (CB) : Free Stock Analysis Report
KLA Corporation (KLAC) : Free Stock Analysis Report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
T-Mobile US, Inc. (TMUS) : Free Stock Analysis Report
Booking Holdings Inc. (BKNG) : Free Stock Analysis Report
